However, therapeutic application of Stat3-antisense oligonucleotides or IL11 antagonists to gp130Y757F mice, suggest that growth and maintenance of gastric tumours remains dependent on the continuous activation of Stat3 [31,93]. Here, STAT3 is linked to gastric neoplasm.